Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback